Clinical trial

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis

NCT03830619

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention collect samples Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-01-01

PhaseN/A

Conditions

Lung Cancer (Diagnosis)unresolved

Interventions

collect samplesDIAGNOSTIC_TEST

Sponsors & collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologylead sponsor

Mapped research locations

WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03830619 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.